Latest Publications
Praesent lectus leo, convallis id neque nec, ultrices euismod nibh. Sed ac rhoncus quam. Fusce tristique tellus diam, vel porta eros iaculis vitae.
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma
Elizabeth C. Lewis, Jacqueline M. Kraveka, William Ferguson, Don Eslin, Valerie I. Brown, Genevieve Bergendahl, William Roberts, Randal K. Wada, Javier Oesterheld, Deanna Mitchell, Jessica Foley, Peter Zage, Jawhar Rawwas, Maria Rich, Elizabeth Lorenzi, Kristine[...]
Maintenance DFMO Increases Survival in High Risk Neuroblastoma
Giselle L. Saulnier Sholler, William Ferguson, Genevieve Bergendahl, Jeffrey P. Bond, Kathleen Neville, Don Eslin, Valerie Brown, William Roberts, Randal K. Wada, Javier Oesterheld, Deanna Mitchell, Jessica Foley, Nehal S. Parikh, Francis Eshun, Peter Zage,[...]
Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses
Shukla GS, Sun YJ, Pero SC, Sholler GS, Krag DN. Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses. J Immunol Methods. 2018 Sep;460:51-62
Molecular Guided Therapy Provides Sustained Clinical Response in Refractory Choroid Plexus Carcinoma
Cornelius A, Foley J, Bond J, Nagulapally AB, Steinbrecher J, Hendricks WP, Rich M, Yendrembam S, Bergendahl G, Trent JM, Sholler GS, Molecular Guided Therapy Provides Sustained Clinical Response in Refractory Choroid Plexus Carcinoma, Front. Pharmacol.,[...]
BKM120 induces apoptosis and inhibits tumor growth in medulloblastoma
Zhao P, Hall J, Durston M, Voydanoff A, VanSickle E, Kelly S, Nagulapally, AB, Bond, J, Saulnier Sholler, G BKM120 induces apoptosis and inhibits tumor growth in medulloblastoma. PLoS ONE June 29, 2017, 12(6): e0179948. https://doi.org/10.1371/journal.pone.0179948
Inhibition of Neuroblastoma Cell Growth by Difluoromethylornithine (DFMO) and Bortezomib through Suppression of LIN28 and MYCN
Rich M, Zhao P, Nagulapally A, Bond J, Saulnier Sholler G. Inhibition of Neuroblastoma Cell Growth by Difluoromethylornithine (DFMO) and Bortezomib through Suppression of LIN28 and MYCN, Journal of Cancer Therapy, June 2017, 8, 561-578
In The Press
Praesent lectus leo, convallis id neque nec, ultrices euismod nibh. Sed ac rhoncus quam. Fusce tristique tellus diam, vel porta eros iaculis vitae.
On-Going Research
Praesent lectus leo, convallis id neque nec, ultrices euismod nibh. Sed ac rhoncus quam. Fusce tristique tellus diam, vel porta eros iaculis vitae.